DrugCard

DrugCard, an AI-powered tool tailored for the pharmaceutical sector, excels in localized literature screening, enhancing drug safety while ensuring regulatory compliance. Its unique features include continuous and transparent screening, enabling pharmaceutical companies to stay informed about local market developments. It adapts seamlessly to new markets and supports multiple languages and suppliers without requiring substantial capital investments, making it cost-effective. With over 100 supported languages and access to medical journals from 35 countries, it maintains high accuracy in scanning PDFs. DrugCard serves Contract Research Organizations (CROs), enabling efficient project management and improved screening outcomes. Marketing Authorization Holders (MAHs) can opt for in-house screening to mitigate compliance and reputation risks, while freelancers can save time on literature screening for more value-added tasks. DrugCard offers the pharmaceutical industry a reliable and efficient solution for localized literature screening, streamlining drug safety processes, and ensuring compliance with regulatory standards.